期刊文献+

顺铂或奥沙力铂联合热疗对人胃癌细胞系BGC-823抑制作用的比较 被引量:3

Comparison of either cisplatin or oxaliplatin with hyperthermia against human gastric cancer cell line BGC-823
在线阅读 下载PDF
导出
摘要 目的:比较顺铂或奥沙力铂联合热疗对人未分化胃腺癌细胞系BGC823增殖的抑制作用。方法:使用MTT法检测细胞增殖,确定顺铂和奥沙力铂对BGC823抑制的工作浓度,并以该浓度进行化疗或与热疗联合应用,根据Veleriote法判断热、化疗联合应用后24h或48h的作用效果,并将顺铂和奥沙力铂联合热疗的作用进行比较。结果:以20%~30%抑制率的药物浓度作为试验的工作浓度,确定顺铂和奥沙力铂的工作浓度分别为1μg/ml和5μg/ml。单纯43℃热疗1h后,在24h时和48h时对BGC823的抑制作用无统计学意义(P>0.05);应用顺铂1μg/ml和奥沙力铂5μg/ml后24h对BGC823无显著的抑制作用(P>0.05),48h时呈现显著的抑制作用(P<0.01)。应用两药联合43℃热疗1h,在24h和48h对BGC823均有显著的抑制作用(P<0.05),随着时间的延长,对BGC823的抑制作用增强(P<0.05)。单药化疗在24h或48h时,两药的抑制作用无统计学差异(P>0.05),顺铂联合热疗对BGC823的抑制作用在24h和48h时均比奥沙力铂联合热疗的抑制作用强(P<0.05)。根据Veleriote法判断:顺铂1μg/ml联合热疗在24h和48h时均呈明显的协同作用;奥沙力铂5μg/ml联合热疗在24h时产生次加作用,在48h产生协同作用。结论:顺铂或奥沙力铂联合热疗在24h和48h时呈现次加或协同作用,两种药物相比,顺铂比奥沙力铂作用更强。 To compare the anticancer effect of cisplatin or oxaliplatin combined with hyperthermia against human undifferentiated gastric adenocarcinoma cell line BGC-823. Methods : The working concentrations of cisplatin and oxaliplatin against BGC-823 were determined by MTT assay that has been developed for quantitative evaluation of the proliferation of cells. Then the chemotherapy or hyperthermia, singly or concurrently, were used and the cell survival rates were obtained. The anticancer effect was evaluated and compared by Veleriote method at 24 h or 48 h. Results : The working concentrations were defined as the concentration causing 20% ~30% inhibition rate. They turned out to be 1μg/ml and 5 μg/ml of cisplatin and oxaliplatin, respectively. Exposing to 43 ℃ hyperthermia for 1 hour did not show obvious inhibition to BGC-823 at 24 h or 48 h (P 〉 0.05 ). The chemotherapies with cispla- tin 1 μg/ml or oxaliplatin 5μg/ml did not exhibit obvious inhibition to BGC-823 at 24 h ( P 〉 0.05 ), but they did at 48 h( P 〈 0.01 ). The combination of cisplatin or oxaliplatin with 43℃ hyperthermia for 1 hour showed obvious inhibition to BGC-823 at 24 h and 48 h. (P 〈 0.05 ). And the effect of chemohyperthermia was amplified as the time prolonged (P 〈 0.05 ). There was no difference between the two drugs at 24 h and 48 h when used singly. The inhibitory effect of cisplatin was much higher than that of the oxaliplatin when used with hyperthermia. Judged with the Veleriote method at 24 h and 48 h, there was obvious synergism of cisplatin 1 ℃g/ml combined with hyperthermia. Oxaliplatin combined with hyperthermia exhibited subaddictive effect at 24 h and synergism at 48 h. Conclusion : The combination of cisplatin or oxaliplatin and 43℃ hyperthermia for 1 hour showed subaddictive effect or synergism to the inhibition of human undifferentiated gastric adenocarcinoma cell line BGC-823, and cisplatin is much better than oxaliplatin when combined with hyperthermia.
出处 《医学研究生学报》 CAS 2006年第4期310-314,共5页 Journal of Medical Postgraduates
基金 江苏省卫生厅重点基金资助项目(批准号:H200349)
关键词 胃癌细胞系 热疗 热化疗 顺铂 奥沙力铂 Gastric cancer cell line Hyperthermia Chemohyperthermia Cisplatin Oxaliplatin
  • 相关文献

参考文献9

  • 1Othman T,Goto S,Lee JB,et al.Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel[J].Pharmacology,2001,62(4):208-212.
  • 2Rietbroek RC,van de Vaart PJ,Haveman J,et al.Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW1573 cells[J].J Cancer Res Clin Oncol,1997,123(1):6-12.
  • 3Mohamed F,Marchettini P,Stuart OA,et al.Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia[J].Ann Surg Oncol,2003,10(4):463-468.
  • 4Atallah D,Marsaud V,Radanyi C,et al.Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines[ J ].Int J Hyperthermia,2004,20(4):405-419.
  • 5Hegewisch-Becker S,Gruber Y,Corovic A,et al.Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin,high-dose leucovorin and 5-fluorouraci148-hour continuous infusion in pretreated metastatic colorectal cancer:a phase Ⅱ study[J].Ann Oncol,2002,13(8):1197-1204.
  • 6Atallah D,Marsaud V,Radanyi C,et al.Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines[ J ].Int J Hyperthermia,2004,20(4):405-419.
  • 7鹿红,陈龙邦.热疗在恶性肿瘤综合治疗中的作用[J].医学研究生学报,2004,17(5):458-460. 被引量:22
  • 8Riccardi A,Ferlini C,Meco D,et al.Antitumour activity of oxaliplatin in neuroblastoma cell lines[ J].Eur J Cancer,1999,35(1):86-90.
  • 9Arnould S,Hennebelle I,Canal P,et al.Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines[ J ].Eur J Cancer,2003,39(1):112-119.

二级参考文献20

  • 1[1]Robins HI, Grosen E, Katschinski DM et al. Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid disease [J]. J Rheumatol, 1999, 26(12):2513-2516.
  • 2[2]Katschinski DM, Benndorf R, Wiedemann GJ et al. Heat shock protein antibodies in sarcoma patients undergoing 41.8 C whole body hyperthermia[J]. J Immunother, 1999, 22(1):67-70.
  • 3[3]Morita M, Kuwano H, Araki K et al. Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer[J]. Int J Radiat Oncol Biol Phys, 2001, 49(5):1259-1266.
  • 4[4]Masunaga S, Ono K, Takahashi A et al. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status[J]. Cancer Sci, 2003, 94(1):125-133.
  • 5[5]Roca C, Primo L, Valdembri D et al. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism[J]. Cancer Res, 2003, 63(7):1500-1507.
  • 6[6]Ressel A, Weiss C, Feyerabend T. Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival[J]. Int J Radiat Oncol Biol Phys, 2001, 49(4):1119-1125.
  • 7[7]Van der Zee J. Heating the patient: a promising approach?[J] Ann Oncol, 2002, 13(8):1173-1784.
  • 8[8]Hehr T, Budach W, Lamprecht U et al.Experimental thermoradiotherapy in malignant hepatocellular carcinoma[J]. Int J Radiat Oncol Biol Phys, 2003, 55(5):1374-1380.
  • 9[10]Arends J.Effects of a combined thermochemotherapy on markers of apoptosis, differentiation and adhesion in the human mammary carcinoma MX-1.A light microscopic and immunohistochemical study[J]. Anat Anz, 2000,182(4):339-347.
  • 10[11]Stein U, Jurchott K, Walther W et al. Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters[J]. J Biol Chem, 2001, 276(30):28562-28569.

共引文献21

同被引文献24

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部